Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Zynerba Pharmaceuticals, Inc. (ZYNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/11/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/11/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/11/2023 8-K Quarterly results
10/11/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/04/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/29/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/27/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/27/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/24/2023 SC 13D Harmony Biosciences Holdings, Inc. reports a 13.1% stake in ZYNERBA PHARMACEUTICALS, INC.
08/15/2023 3 Jones Kenneth T (See Remarks) has filed a Form 3 on Zynerba Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy